A central role for inhibition of HDAC activity by ABC294640 resulting in multifaceted, but complimentary, downstream modulation of c-Myc, p21, phospho-Rb and RRM2 expression all combine to attenuate tumor cell proliferation and increase sensitivity to gemcitabine. The gene discussed is RRM2; the disease is neoplasm.